Member Info for Trendz

Would be nice to see us slowly return to 125-140

Look at Seres! Absolutely flying in the US. Almost 3 billion market cap. DDDD risk reward profile is the best I can see on AIM - a potential 10-20 bagger here, and thats just to catch up Seres.

Good news - all part of the pipeline of news coming to us in the short to medium term. I suspect that this will help shift the scientific community to becoming LBP believers! So exciting that 4D Pharma are at the forefront - one only valued at 125 million. 10 bagger in a couple of years this.

Yes - sadly the damage has been done as to get back to where we were is an 80 percent share price rise. I think 140-150 by end of the month

Noticed that! Naughty... market sensitive that for sure. Cracking interview and echoes all my views. £1. 3 years this will be £10 with a £1billion market cap. Chance to make your millions here if you can afford to have 100 grand tied up.

Thanks for sharing

Agree - the market (currently made up of day traders) is treating this like an abandoned oil well drill! Market cap 125m - to me this is grossly undervalued given the IP and drug portfolio. Holding for gold

Big picture - the company's SP has been trading below its 200 day moving average for years (since mid-2016). The SP flipped to trading above the 200 moving average in the second week of August. I wish I had invested earlier here (always the way!) but having spent a month or so researching the company, I only recently decided to dive in (average of 120 - will be higher than most). The future looks very bright here and 2020 has been big for the company in many ways! I'm stuffing my shares away for 3 years at least. But in the short term (within the next 6 months) I can see some big catalysts here. Namely, NASDAQ listing and on-boarding of new supportive US investors, oncology update, Merck partnership update / milestone payments, Covid trial update, IBS partnership, updates on all the other trails!

Wiped off the market cap - is this justified? Sentiment can change fast. I'm holding and buying at these levels. Large position now!

Great entry price again today. Looking forward to Covid trial results (and the rest!). I think the Covid trial results could be huge given that Covid will be around for a long time and the resulting benefits to the Asthma drug. Suspect that the company is holding off on the next capital raise until next year, in order to get more bang for buck.

other than the spread betting TR1 - for me, i'm happy to see no material shareholders have been selling - The crash last week was retail driven. Bull flag for me.

Probably a new partnership before then tho

Evelo biosciences also doing really well. DDDD curse is being on ****ty AIM. I can see NASDAQ listing with big capital raise coming

https://www.sharebuyers.co.uk/shares/4dpharma-shares-going-for-growth-trailblazer-ready-to-realise-true-value/

Email alert from research tree:

The level of disclosed Short Interest in DDDD has changed materially.

Short Interest has moved from 0.62% on the previous trading day to 0.00% today. That is a movement of -0.62 percentage points.

Friend of mine is spread betting DDDD - he is saying that you can't open a long position on IG Index. Anyone know why that might be?

And to the chartists - we are now trading above the 200 and 50 moving averages. Would any of the chartists calling 80 pence care to comment on the price action - genuinely interested to hear views.

Rationale thinking now prevailing over panic ensued selling

https://www.4dpharmaplc.com/application/files/2315/9842/2512/4D_pharma_Management_presentation_Aug_2020.pdf

Page 19 - DDDD is an infinitely better company than all those mentioned (excluding perhaps Seres, which is a separate debate). On that basis, we are 50% off the US valuations. So, if this were a NASDAQ company, the market cap would be at least 100% higher and given the IP portfolio and much better pipeline, i would suggest far far higher.

Yes, DDDD is bubble stock! HA. Flat on the year and valued at 130m. Big bubble in my book. materially undervalued